Tsuda Etsuko, Tsujii Nobuyuki, Hayama Yosuke
Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
J Pediatr. 2017 Sep;188:70-74.e1. doi: 10.1016/j.jpeds.2017.05.055. Epub 2017 Jun 26.
To clarify the occurrence of cardiac events based on the maximal diameter of the maximal coronary artery aneurysm (CAA) in Kawasaki disease (KD).
Two hundred fourteen patients (160 male and 54 female) who had had at least 1 CAA in the selective coronary angiogram less than 100 days after the onset of KD were studied. We measured the maximal CAA diameters in the major branches of the initial coronary angiograms. Death, myocardial infarction and coronary artery revascularization were included as cardiac events in this study. We divided the patients into three groups based on the maximal CAA diameter (large ≥8.0 mm; medium ≥6.0 mm and <8.0 mm; small <6.0 mm). Further, we also analyzed the cardiac events based on laterality of maximal CAA (bilateral, unilateral) and body surface area (BSA).
Cardiac events occurred in 44 patients (21%). For BSA < 0.50 m, the 30-year cardiac event-free survival in the large and medium groups was 66% (n = 38, 95% CI, 49-80) and 62% (n = 27, 95% CI, 38-81), respectively. For BSA ≥ 0.50 m, that in large group was 54% (n = 58, 95% CI, 40-67). There were no cardiac events in the medium group for BSA ≥0.50 m (n = 36) and the small group (n = 56). In the large analyzed group, the 30-year cardiac event-free survival in the bilateral and unilateral groups was 40% (n = 48, 95% CI, 27-55) and 78% (n = 48, 95% CI, 63-89), respectively (P < .0001).
The group with the highest risk of cardiac events was the patient group with the maximal CAA diameter ≥6.0 mm with BSA < 0.50 m and the maximal CAA diameter ≥8.0 mm with BSA ≥ 0.50 m. At 30 years after the onset of KD, cardiac event-free survival was about 60%. Given the high rate of cardiac events in this patient population, life-long cardiovascular surveillance is advised.
基于川崎病(KD)中最大冠状动脉瘤(CAA)的最大直径,阐明心脏事件的发生情况。
对214例患者(160例男性,54例女性)进行研究,这些患者在KD发病后不到100天的选择性冠状动脉造影中至少有1个CAA。我们测量了初次冠状动脉造影主要分支中的最大CAA直径。本研究将死亡、心肌梗死和冠状动脉血运重建作为心脏事件。根据最大CAA直径将患者分为三组(大:≥8.0毫米;中:≥6.0毫米且<8.0毫米;小:<6.0毫米)。此外,我们还根据最大CAA的部位(双侧、单侧)和体表面积(BSA)分析了心脏事件。
44例患者(21%)发生了心脏事件。对于BSA<0.50平方米,大组和中组30年无心脏事件生存率分别为66%(n = 38,95%CI,49 - 80)和62%(n = 27,95%CI,38 - 81)。对于BSA≥0.50平方米,大组为54%(n = 58,95%CI,40 - 67)。对于BSA≥0.50平方米的中组(n = 36)和小组(n = 56),未发生心脏事件。在分析的大组中,双侧组和单侧组30年无心脏事件生存率分别为40%(n = 48,95%CI,27 - 55)和78%(n = 48,95%CI,63 - 89)(P<0.0001)。
心脏事件风险最高的组是最大CAA直径≥6.0毫米且BSA<0.50平方米以及最大CAA直径≥8.0毫米且BSA≥0.50平方米的患者组。在KD发病30年后,无心脏事件生存率约为60%。鉴于该患者群体中心脏事件发生率较高,建议进行终身心血管监测。